Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of HLA-DRB1*1501-restricted T-cell epitopes from human prostatic acid phosphatase.

The Prostate - 1 Jul 2007

Klyushnenkova Elena N, Kouiavskaia Diana V, Kodak James A, Vandenbark Arthur A, Alexander Richard B

Abstract excerpt

BACKGROUND: The crucial role of CD4 T-cells in anti-tumor immune response is widely recognized, yet the identification of HLA class II-restricted epitopes derived from tumor antigens has lagged behind compared to class I epitopes. This is particularly true for prostate cancer. Based on the hypothesis that successful cancer immunotherapy will likely resemble autoimmunity, we searched for the CD4 T-cell epitopes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acid Phosphatase
Share to Cancer Vaccines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD4-Positive T-Lymphocytes

Share to Epitopes

Share to HLA-DR Antigens

Share to HLA-DR2 Antigen

Share to HLA-DRB1 Chains

Share to Protein Tyrosine Phosphatases

Source

Identifiers

PMID: 17455230
DOI: 10.1002/pros.20575

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of HLA-DRB1*1501-restricted T-cell epitopes from human prostatic acid phosphatase.PMID 17455230Read ↗

Prostate-related antigen-derived new peptides having the capacity of inducing prostate cancer-reactive CTLs in HLA-A2+ prostate cancer patients.Semantic proximity Read ↗

Naturally occurring prostate cancer antigen-specific T cell responses of a Th1 phenotype can be detected in patients with prostate cancer.Semantic proximity Read ↗

Immunogenetics of prostate cancer and benign hyperplasia--the potential use of an HLA-G variant as a tag SNP for prostate cancer risk.Semantic proximity Read ↗

Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype alleles.Semantic proximity Read ↗

Plant-Derived Recombinant Macromolecular PAP-IgG Fc as A Novel Prostate Cancer Vaccine Candidate Eliciting Robust Immune ResponsesSemantic proximity Read ↗

Induction of human cytotoxic T lymphocytes specific for prostate-specific antigenSemantic proximity Read ↗

Identification of MHC class II-restricted T-cell epitopes in prostate-specific membrane antigen.Semantic proximity Read ↗

Granulomatous prostatitis linked to HLA-DRB1*1501.Semantic proximity Read ↗

Human prostate‐infiltrating CD8 <sup>+</sup> T lymphocytes are oligoclonal and PD‐1 <sup>+</sup>Semantic proximity Read ↗

Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice.Semantic proximity Read ↗

Immune cell single-cell RNA sequencing analyses link an age-associated T cell subset to symptomatic benign prostatic hyperplasiaSemantic proximity Read ↗

Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 <sup>+</sup> T LymphocytesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.